• Cell and Gene Therapy Market Header

The global market for cell and gene therapy in 2020 reached an estimated $3.8 billion in 2020 according to Kalorama Information. How do you keep up with the business? How do you know what news is important? How can you know if scientific developments are changing the business outlook? The only way is to keep updated with a regularly published and authoritative source.

CELL AND GENE THERAPY BUSINESS OUTLOOK

A new twice-monthly publication dedicated to cell and gene therapy. Cell and Gene Therapy Business Outlook offers the following:

  • Market Sizing and Forecasting of CAGT Markets
  • Executive News Summaries
  • Deals Between CAGT Companies Tracked
  • Financing
  • Trends in the Industry
  • Important Science That Will Shape Tomorrow’s Business
  • Company Profiling and Quarterly Results Summaries
  • Updates on Pipelines and Important Clinical Trials
  • Cell and Gene Therapy Tools
  • Cell and Gene Therapy CMOs
  • And More

Deals Table – In Every Issue, the Last Three Months of Important Cell and Gene Therapy Partnerships, Mergers, Technology Transfers

Market Analysis of a Cell and Gene Therapy Segment in Every Issue!

MARKET REPORTS

Cell and Gene Therapy Report Results

Science and Medicine Group publishes research reports covering the Cell and Gene Therapy Market on a variety of topics:

ANALYST BLOGS

, ,

This Week in Cell and Gene Therapy: 11 New Developments to Know (September 12, 2022)

There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Kite Pharma, a Gilead Company based in Santa Monica, CA, has announced that the European…
, ,

This Week in Cell and Gene Therapy: 8 New Developments to Know (August 22, 2022)

There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Prescient Therapeutics, a clinical stage oncology company based in Melbourne, Australia,…
, ,

This Week in Cell and Gene Therapy: 14 New Developments to Know (May 23, 2022)

There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Vertex Pharmaceuticals, based in Boston, MA, has announced plans for a 344,000 square-foot…
, ,

This week in Cell and Gene Therapy: 14 New Developments to Know (May 9, 2022)

There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. The U.S. FDA has lifted clinical holds on two Phase III clinical studies evaluating…
, ,

$54.4 Billion in Deals and Counting: Analyzing Three Quarters of Cell and Gene Therapy Funding

Over 54 BN across funding mechanisms.  Private, VC, SPAC and and IPO Over 20Billion The enormous amount of funding presages confidence in discoveries of future marketable products as well as platforms in cell and gene therapy.  With an aggressive…

COVID-19 AND CELL AND GENE THERAPY PIPELINE

The market for 2025 is estimated at $12,954 million and will more than double five years after to $29,960 million for 2030. Sales from oncology, cardiovascular-blood and musculoskeletal conditions will contribute strongly to market performance. Genetic conditions will also provide steady growth.

It is an exciting and interesting time to be involved in the cell and gene therapy industry. The science is moving ahead and now the industry needs to industrialize and standardize the manufacturing and commercialization of products. The industry is moving in the direction of a standardized set-up and a closed automated system.

Consequently, cell and gene therapy products are transforming the treatment of cancers and genetic diseases. Additionally, cell and gene therapies are expanding into other areas of medicine including autoimmune diseases, cardiovascular diseases, musculoskeletal disease, dermatological diseases and many others.

ONLINE COMMUNITIES

Extend Your Audience Reach

Science and Medicine Group hosts online communities of scientific and clinical researchers designed to provide late-breaking news and information to professionals working in laboratories. Our digital marketing offering includes inline website ads, banner ads, direct email delivery, company profile/landing pages, newsletter ads, community sponsorship and more.

Science Advisory Board (SAB): Engage and connect with our drug development & discovery community members who work toward the medical applications of cell analysis and more.

Download SAB Media Kit

LabPulse: Reach and engage with lab managers, lab directors, lab technicians, pathologists, molecular biologists, clinical chemists and molecular diagnostics professionals who are on the cutting edge of clinical laboratory advancements.

Download LabPulse Media Kit

Register for Access Login for Access


Register for Access Login for Access

Lost your password? Register